• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子受体 CCR5 和 CXCR4 二聚化的结构基础。

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4.

机构信息

Department of Life and Environmental Sciences - New York-Marche Structural Biology Centre (NY-MaSBiC), Polytechnic University of Marche, Via Brecce Bianche, 60131, Ancona, Italy.

Neuronal Death and Neuroprotection Unit, Department of Neuroscience, Mario Negri Institute for Pharmacological Research-IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

出版信息

Nat Commun. 2023 Oct 13;14(1):6439. doi: 10.1038/s41467-023-42082-z.

DOI:10.1038/s41467-023-42082-z
PMID:37833254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10575954/
Abstract

G protein-coupled receptors (GPCRs) are prominent drug targets responsible for extracellular-to-intracellular signal transduction. GPCRs can form functional dimers that have been poorly characterized so far. Here, we show the dimerization mechanism of the chemokine receptors CCR5 and CXCR4 by means of an advanced free-energy technique named coarse-grained metadynamics. Our results reproduce binding events between the GPCRs occurring in the minute timescale, revealing a symmetric and an asymmetric dimeric structure for each of the three investigated systems, CCR5/CCR5, CXCR4/CXCR4, and CCR5/CXCR4. The transmembrane helices TM4-TM5 and TM6-TM7 are the preferred binding interfaces for CCR5 and CXCR4, respectively. The identified dimeric states differ in the access to the binding sites of the ligand and G protein, indicating that dimerization may represent a fine allosteric mechanism to regulate receptor activity. Our study offers structural basis for the design of ligands able to modulate the formation of CCR5 and CXCR4 dimers and in turn their activity, with therapeutic potential against HIV, cancer, and immune-inflammatory diseases.

摘要

G 蛋白偶联受体(GPCRs)是负责细胞外到细胞内信号转导的重要药物靶点。GPCR 可以形成功能二聚体,但迄今为止对其了解甚少。在这里,我们通过一种名为粗粒元分子动力学的先进自由能技术,展示了趋化因子受体 CCR5 和 CXCR4 的二聚化机制。我们的结果再现了在微小时间尺度上发生的 GPCR 之间的结合事件,揭示了三个研究系统(CCR5/CCR5、CXCR4/CXCR4 和 CCR5/CXCR4)中每一种的对称和不对称二聚体结构。TM4-TM5 和 TM6-TM7 跨膜螺旋是 CCR5 和 CXCR4 的首选结合界面。所鉴定的二聚体状态在配体和 G 蛋白结合位点的可及性上存在差异,表明二聚化可能代表一种精细的变构机制,以调节受体活性。我们的研究为设计能够调节 CCR5 和 CXCR4 二聚体形成及其活性的配体提供了结构基础,从而具有针对 HIV、癌症和免疫炎症性疾病的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/5aab4207b9db/41467_2023_42082_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/57959fd7e574/41467_2023_42082_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/ed5c987865f4/41467_2023_42082_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/0f669bbfbd66/41467_2023_42082_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/33c38f28d6b7/41467_2023_42082_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/f6bafe131add/41467_2023_42082_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/98314d7679d8/41467_2023_42082_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/d1da33df7b3d/41467_2023_42082_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/5aab4207b9db/41467_2023_42082_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/57959fd7e574/41467_2023_42082_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/ed5c987865f4/41467_2023_42082_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/0f669bbfbd66/41467_2023_42082_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/33c38f28d6b7/41467_2023_42082_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/f6bafe131add/41467_2023_42082_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/98314d7679d8/41467_2023_42082_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/d1da33df7b3d/41467_2023_42082_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3475/10575954/5aab4207b9db/41467_2023_42082_Fig8_HTML.jpg

相似文献

1
Structural basis of dimerization of chemokine receptors CCR5 and CXCR4.趋化因子受体 CCR5 和 CXCR4 二聚化的结构基础。
Nat Commun. 2023 Oct 13;14(1):6439. doi: 10.1038/s41467-023-42082-z.
2
Multiple mechanisms of self-association of chemokine receptors CXCR4 and CCR5 demonstrated by deep mutagenesis.通过深度诱变展示趋化因子受体 CXCR4 和 CCR5 的多种自缔合机制。
J Biol Chem. 2023 Oct;299(10):105229. doi: 10.1016/j.jbc.2023.105229. Epub 2023 Sep 9.
3
Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol.紧密相关但又各具特点:G 蛋白偶联趋化因子受体的同源和异源二聚化模式及其受胆固醇的精细调节。
PLoS Comput Biol. 2018 Mar 12;14(3):e1006062. doi: 10.1371/journal.pcbi.1006062. eCollection 2018 Mar.
4
Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.荧光共振能量转移成像显示趋化因子结合可调节CXCR4和CCR5受体的异二聚体。
PLoS One. 2008;3(10):e3424. doi: 10.1371/journal.pone.0003424. Epub 2008 Oct 16.
5
Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity.人巨细胞病毒编码的 UL33 和 UL78 与宿主 CCR5 和 CXCR4 形成异源二聚体,损害其 HIV 辅助受体活性。
Blood. 2012 May 24;119(21):4908-18. doi: 10.1182/blood-2011-08-372516. Epub 2012 Apr 10.
6
CXCR4-CCR5: a couple modulating T cell functions.CXCR4-CCR5:一对调节T细胞功能的组合
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10101-6. doi: 10.1073/pnas.0804286105. Epub 2008 Jul 15.
7
Functional consequences of chemically-induced β-arrestin binding to chemokine receptors CXCR4 and CCR5 in the absence of ligand stimulation.在没有配体刺激的情况下,化学诱导的β-arrestin 与趋化因子受体 CXCR4 和 CCR5 结合的功能后果。
Cell Signal. 2017 Oct;38:201-211. doi: 10.1016/j.cellsig.2017.07.010. Epub 2017 Jul 18.
8
Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.CCR2-V64I多态性对1型人类免疫缺陷病毒共受体活性以及CCR2b、CCR3、CCR5和CXCR4趋化因子受体功能的影响。
J Virol. 1998 Sep;72(9):7450-8. doi: 10.1128/JVI.72.9.7450-7458.1998.
9
High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1.合成人GPCR趋化因子受体CCR5、CCR3、CXCR4和CX3CR1的高水平生产、溶解及纯化。
PLoS One. 2009;4(2):e4509. doi: 10.1371/journal.pone.0004509. Epub 2009 Feb 18.
10
Multiplex detection of homo- and heterodimerization of g protein-coupled receptors by proximity biotinylation.通过邻近生物素化对G蛋白偶联受体的同源和异源二聚化进行多重检测。
PLoS One. 2014 Apr 1;9(4):e93646. doi: 10.1371/journal.pone.0093646. eCollection 2014.

引用本文的文献

1
The contributing role of CCR5 in dementia.CCR5在痴呆症中的促成作用。
Front Neurol. 2025 Jul 9;16:1545302. doi: 10.3389/fneur.2025.1545302. eCollection 2025.
2
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.组成型CXCR4寡聚体的破坏会损害淋巴瘤的致癌特性。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2424186122. doi: 10.1073/pnas.2424186122. Epub 2025 Jun 11.
3
Targeting the chemokine receptor CXCR4 for cancer therapies.以趋化因子受体CXCR4为靶点进行癌症治疗。

本文引用的文献

1
Computationally designed GPCR quaternary structures bias signaling pathway activation.计算设计的 G 蛋白偶联受体四级结构偏向信号通路激活。
Nat Commun. 2022 Nov 11;13(1):6826. doi: 10.1038/s41467-022-34382-7.
2
The transmembrane domains of GPCR dimers as targets for drug development.G蛋白偶联受体二聚体的跨膜结构域作为药物开发的靶点。
Drug Discov Today. 2023 Jan;28(1):103419. doi: 10.1016/j.drudis.2022.103419. Epub 2022 Oct 26.
3
Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor.
Biomark Res. 2025 May 1;13(1):68. doi: 10.1186/s40364-025-00778-y.
4
Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A receptor activation mechanism.分钟时间尺度的自由能计算揭示了腺苷A受体激活机制中的一种假活性状态。
Chem. 2024 Dec 12;10(12):3678-3698. doi: 10.1016/j.chempr.2024.08.004.
5
GPCR dimerization: Drug discovery aspects and targets in renin-angiotensin systems.G蛋白偶联受体二聚化:肾素-血管紧张素系统中的药物发现方面及靶点
FASEB Bioadv. 2025 Jan 31;7(3):e1486. doi: 10.1096/fba.2024-00180. eCollection 2025 Mar.
6
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.G蛋白偶联受体的功能动力学揭示了药物发现的新途径。
Nat Rev Drug Discov. 2025 Apr;24(4):251-275. doi: 10.1038/s41573-024-01083-3. Epub 2025 Jan 2.
7
Interaction and dynamics of chemokine receptor CXCR4 binding with CXCL12 and hBD-3.趋化因子受体CXCR4与CXCL12和人β-防御素3的相互作用及动力学
Commun Chem. 2024 Sep 13;7(1):205. doi: 10.1038/s42004-024-01280-6.
8
Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain.通过靶向 TM V-TMVI 结构域来实现 CXCR4:CXCL12 轴的变构调节,从而实现受体纳米簇的靶向。
Elife. 2024 Sep 9;13:RP93968. doi: 10.7554/eLife.93968.
9
Early Events in βAR Dimer Dynamics Mediated by Activation-Related Microswitches.βAR 二聚体动力学的早期事件由激活相关微动开关介导。
J Membr Biol. 2024 Dec;257(5-6):323-344. doi: 10.1007/s00232-024-00324-1. Epub 2024 Sep 6.
10
Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy.肿瘤微环境中的趋化因子:对肺癌和免疫治疗的影响
Front Immunol. 2024 Jul 16;15:1443366. doi: 10.3389/fimmu.2024.1443366. eCollection 2024.
由于 G 蛋白偶联的血小板激活因子受体寡聚化导致的信号偏向。
Nat Commun. 2022 Oct 26;13(1):6365. doi: 10.1038/s41467-022-34056-4.
4
GPCR heteromers: An overview of their classification, function and physiological relevance.G 蛋白偶联受体异源二聚体:分类、功能和生理相关性概述。
Front Endocrinol (Lausanne). 2022 Aug 30;13:931573. doi: 10.3389/fendo.2022.931573. eCollection 2022.
5
Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone.使用具有刚性寡聚脯氨酸骨架的二价配体探索G蛋白偶联受体的信号空间。
Proc Natl Acad Sci U S A. 2021 Nov 30;118(48). doi: 10.1073/pnas.2108776118.
6
Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5.趋化因子受体 CCR5 的化学引诱物识别和受体激活的结构基础。
Nat Commun. 2021 Jul 6;12(1):4151. doi: 10.1038/s41467-021-24438-5.
7
Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.CC 趋化因子受体 5 激动剂激活的结构基础。
Sci Adv. 2021 Jun 16;7(25). doi: 10.1126/sciadv.abg8685. Print 2021 Jun.
8
Evaluating the Efficiency of the Martini Force Field to Study Protein Dimerization in Aqueous and Membrane Environments.评估 Martini 力场研究水溶液和膜环境中蛋白质二聚化的效率。
J Chem Theory Comput. 2021 May 11;17(5):3088-3102. doi: 10.1021/acs.jctc.0c00507. Epub 2021 Apr 29.
9
Perspectives on High-Throughput Ligand/Protein Docking With Martini MD Simulations.基于Martini分子动力学模拟的高通量配体/蛋白质对接研究展望
Front Mol Biosci. 2021 Mar 29;8:657222. doi: 10.3389/fmolb.2021.657222. eCollection 2021.
10
Martini 3: a general purpose force field for coarse-grained molecular dynamics.马蒂尼 3 模型:一种通用的粗粒化分子动力学力场。
Nat Methods. 2021 Apr;18(4):382-388. doi: 10.1038/s41592-021-01098-3. Epub 2021 Mar 29.